Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perisolv and hyaDent BG for Residual Periodontal Pockets
NCT06438354Phase 4Completed
- Sponsor
- University of Witten/Herdecke
- Start
- Aug 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, randomised trial of Perisolv and cross-linked hyaluronic acid in periodontitis (2 arms), sponsored by University of Witten/Herdecke. Primary endpoint: Clinical Attachment Level at 9 months. Started Aug 2022; status: completed.
02
Drugs
Perisolvcross-linked hyaluronic acid
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT06438354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06438354.